NICE rejects Zurampic for hyperuricaemia in gout patients
Cost regulators for the NHS in England and Wales have published draft guidelines barring adults with gout from routine access to Gruenenthal’s Zurampic-based therapy for treating hyperuricaemia.
Read More
